Phlow Corp. is a U.S.-based public benefit corporation leveraging advanced manufacturing to domestically develop and manufacture active pharmaceutical ingredients (APIs) and finished pharmaceutical products critical to the nation’s healthcare. Utilizing its advanced R&D labs and best-in-class, automated API cGMP capacities ranging from kilo to metric ton scales, Phlow provides customized contract development and manufacturing services for small molecule APIs and key starting materials (KSMs) to pharmaceutical and biotech companies. Phlow’s services reduce costs and waste, improve quality and yield, and provide an environmentally friendly approach to manufacturing cost competitive APIs and KSMs for its customers.

Services include:
– Contract development and manufacturing of small molecule APIs
– Manufacturing of key starting materials (KSMs)
– Advanced research and development (R&D) services
– cGMP compliant manufacturing processes
– Customised manufacturing capacity from kilo to metric ton scales

Phlow Corporation is committed to enhancing the pharmaceutical industry’s supply chain with its innovative and sustainable manufacturing solutions.